Skip to search formSkip to main contentSkip to account menu

AZD2563

Known as: AZD 2563 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
The anti-anaerobic activity of AZD2563, a new oxazolidinone, was compared with that of eight other agents against 201 Gram… 
2002
2002
The in vitro activity of AZD2563, a novel oxazolidinone, was assessed against 595 Gram-positive cocci, comprising recent… 
2002
2002
ABSTRACT The activity of AZD2563 against 250 highly resistant pneumococci and 267 drug-susceptible isolates was determined. The… 
2002
2002
ABSTRACT AZD2563, a novel oxazolidinone, and a selection of comparator drugs that included linezolid, erythromycin, clindamycin… 
2002
2002
Linezolid was the first clinically applied agent from the oxazolidinone class, and AZD2563, a new agent, is described here. Five… 
2002
2002
The in vitro activity of AZD2563, a new oxazolidinone, was compared with that of linezolid, vancomycin, quinupristin/dalfopristin… 
2002
2002
ABSTRACT The activity of a new oxazolidinone antimicrobial, AZD2563, was assessed against >500 clinical isolates of enterococci…